Kim, Kihyun
Kim, Jin Seok
Yoon, Sung-Soo
Yoon, Dok Hyun
Eom, Hyeon-Seok
Lee, Je-Jung
Yim, Hyeon Woo
Park, Misun
Lee, Hojoon
Min, Chang-Ki
,
Funding for this research was provided by:
Amgen Korea
Article History
Received: 7 October 2021
Revised: 10 March 2022
Accepted: 11 March 2022
First Online: 11 May 2022
Declarations
:
: Kihyun Kim, Jin Seok Kim, Sung-Soo Yoon, Dok Hyun Yoon, Hyeon-Seok Eom, Je-Jung Lee, Hyeon Woo Yim, Misun Park and Chang-Ki Min report consultancy and research funding from Amgen Korea. Hojoon Lee reports employment by Amgen Korea.
: This study was approved by the Institutional Review Board (IRB) of Samsung Medical Center (IRB no. SMC2018-08-058-001), the Catholic University of Korea (IRB no. KC18RODI0556), Severance Hospital (IRB no. 4-2018-0633), Seoul National University Hospital (IRB no. H-1810-111-982), Asan Medical Center (IRB no. 2019-0788), National Cancer Center of Korea (IRB no. NCC2019-0105), and Chonnam National University Hwasun Hospital (IRB no. CNUHH-2019-092).
: Not applicable.
: Not applicable.